Delta Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2K | Hold |
77
| – | – | ﹤0.01% | 318 |
|
|
2025
Q1 | $38.3K | Hold |
77
| – | – | ﹤0.01% | 286 |
|
|
2024
Q4 | $40.1K | Hold |
77
| – | – | ﹤0.01% | 286 |
|
|
2024
Q3 | $47.6K | Sell |
77
-2
| -3% | -$1.24K | ﹤0.01% | 273 |
|
|
2024
Q2 | $43.7K | Hold |
79
| – | – | ﹤0.01% | 280 |
|
|
2024
Q1 | $45.9K | Hold |
79
| – | – | ﹤0.01% | 270 |
|
|
2023
Q4 | $41.9K | Buy |
79
+2
| +3% | +$1.06K | ﹤0.01% | 282 |
|
|
2023
Q3 | $39K | Hold |
77
| – | – | ﹤0.01% | 275 |
|
|
2023
Q2 | $40.2K | Hold |
77
| – | – | ﹤0.01% | 282 |
|
|
2023
Q1 | $44.4K | Buy |
77
+40
| +108% | +$23.1K | ﹤0.01% | 247 |
|
|
2022
Q4 | $20.4K | Buy |
+37
| New | +$20.4K | ﹤0.01% | 333 |
|
|
2020
Q3 | – | Sell |
-30
| Closed | -$11K | – | 609 |
|
|
2020
Q2 | $11K | Hold |
30
| – | – | ﹤0.01% | 395 |
|
|
2020
Q1 | $9K | Hold |
30
| – | – | ﹤0.01% | 418 |
|
|
2019
Q4 | $10K | Hold |
30
| – | – | ﹤0.01% | 446 |
|
|
2019
Q3 | $9K | Buy |
+30
| New | +$9K | ﹤0.01% | 447 |
|
|
2018
Q4 | – | Sell |
-7
| Closed | -$2K | – | 681 |
|
|
2018
Q3 | $2K | Sell |
7
-14
| -67% | -$4K | ﹤0.01% | 623 |
|
|
2018
Q2 | $4K | Buy |
21
+7
| +50% | +$1.33K | ﹤0.01% | 558 |
|
|
2018
Q1 | $3K | Hold |
14
| – | – | ﹤0.01% | 583 |
|
|
2017
Q4 | $3K | Hold |
14
| – | – | ﹤0.01% | 566 |
|
|
2017
Q3 | $3K | Hold |
14
| – | – | ﹤0.01% | 542 |
|
|
2017
Q2 | $2K | Hold |
14
| – | – | ﹤0.01% | 562 |
|
|
2017
Q1 | $2K | Buy |
+14
| New | +$2K | ﹤0.01% | 578 |
|